Paper
0
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
Authors
Courtney DiNardo,Abhishek Maiti
Caitlin Rausch,Naveen Pemmaraju,Kiran Naqvi,Naval Daver,Tapan Kadia,Gautam Borthakur,Maro Ohanian,Yesid Alvarado,Ghayas Issa,Guillermo Montalban‐Bravo,Nicholas Short,Musa Yılmaz,Prithviraj Bose,Elias Jabbour,Koichi Takahashi,Jan Burger,Guillermo Garcia‐Manero,Nitin Jain,Steven Kornblau,Philip Thompson,Zeev Estrov,Lucia Masárová,Koji Sasaki,Srđan Verstovšek,Alessandra Ferrajoli,William Weirda,Sa Wang,Sergej Konoplev,Zhining Chen,Sherry Pierce,Jing Ning,Wei Qiao,Farhad Ravandi,Michael Andreeff,John Welch,Hagop Kantarjian,Marina Konopleva,Guillermo Montalbán‐Bravo
+38 authors
,Guillermo García‐ManeroJournal
Published
Sep 6, 2020
Show more
Save
Tip0
TipSave